Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease. Some 138 treatments are being ...

The National Institute for Health and Care Excellence is taking more evidence and is expected to announce its decision in the ...

A third of the drugs that are currently being trialled are 'repurposed' medications that are already being used to tackle other diseases, including diabetes and multiple sclerosis ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Statins, the more commonly used drugs, were also linked to some side effects. For example, some people taking statins might ...

At its second attempt, Novartis has won FDA approval for its cholesterol lowering drug inclisiran, which can reduce levels with just two injections a year. The FDA has approved the drug under the ...

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.